• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Thromb Haemost. Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

tetano

Editor, Senior Moderator
J Thromb Haemost. 2020 Feb 19. doi: 10.1111/jth.14768. [Epub ahead of print] [h=1]Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.[/h]
Tang N[SUP]1[/SUP], Li D[SUP]2[/SUP], Wang X[SUP]1[/SUP], Sun Z[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronavirus pneumonia (NCP) cases were a concern.
[h=4]OBJECTIVES:[/h] To describe the coagulation feature of patients with NCP.
[h=4]METHODS:[/h] Conventional coagulation results and outcomes of consecutive 183 patients with confirmed NCP in Tongji hospital were retrospectively analysed.
[h=4]RESULTS:[/h] The overall mortality was 11.5%, the non-survivors revealed significantly higher D-dimer and fibrin degradation product (FDP) levels, longer prothrombin time and activated partial thromboplastin time compared to survivors on admission (P<0.05). 71.4% of non-survivors and 0.6% survivors met the criteria of disseminated intravascular coagulation during their hospital stay.
[h=4]CONCLUSIONS:[/h] The present study shows that abnormal coagulation results, especially markedly elevated D-dimer and FDP are common in deaths with NCP.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] D-dimer; coagulation parameter; disseminated intravascular coagulation; fibrin degradation product; novel coronavirus pneumonia

PMID: 32073213 DOI: 10.1111/jth.14768
 
Back
Top